Latest News and Press Releases

SAN RAFAEL, Calif., Nov. 6, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that Jean-Jacques Bienaimé, Chief Executive Officer at BioMarin, will present a...

Company Plans to Submit Marketing Applications Starting in 1Q 2013 Conference Call and Webcast to be Held Today at 8:30 a.m. ET SAN RAFAEL, Calif., Nov. 5, 2012 (GLOBE NEWSWIRE) -- BioMarin...

Steady Commercial Growth Supports Advancing Pipeline GALNS Phase 3 Results Expected in 4Q 2012 Conference Call and Webcast to Be Held Today at 5:00 p.m. ET Financial Highlights ($...

NOVATO, Calif., Oct. 4, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that Jean-Jacques Bienaimé, Chief Executive Officer of BioMarin, will host a conference...

NOVATO, Calif., Sept. 26, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) announced today the completion of a Phase 1 study for BMN-111, an analog of C-type Natriuretic Peptide...

Preliminary Phase 2 Results Indicate Convenient and Accelerated Dosing Regimen Identified Conference Call and Webcast to be Held Today at 5:00 p.m. ET NOVATO, Calif., Sept. 26, 2012 (GLOBE...

NOVATO, Calif., Sept. 5, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that Jeff Ajer, the current Vice President, Commercial Operations, the Americas, will be...

NOVATO, Calif., Aug. 23, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that Jean-Jacques Bienaimé, Chief Executive Officer at BioMarin, will present a...

NOVATO, Calif., Aug. 9, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that Dan Spiegelman, Chief Financial Officer at BioMarin, will present a company update at...

Strong Commercial Performance Supporting Development of Five New Chemical Entities With Multiple Key Clinical Readouts by the End of 2012 Conference Call and Webcast to be Held Today at 5:00 p.m....